|
PRKAA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.6514792845519E-12 |
| Normal-vs-Stage2 |
4.91810000002868E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.256600E-01 |
| Stage1-vs-Stage3 |
3.075800E-03 |
| Stage1-vs-Stage4 |
7.89769999953727E-07 |
| Stage2-vs-Stage3 |
1.003830E-01 |
| Stage2-vs-Stage4 |
6.839200E-03 |
| Stage3-vs-Stage4 |
9.122200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62803104331033E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.319850E-03 |
| Caucasian-vs-AfricanAmerican |
2.44340000010723E-07 |
| Caucasian-vs-Asian |
9.241800E-01 |
| AfricanAmerican-vs-Asian |
2.267200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.0637935804757E-12 |
| Male-vs-Female |
8.796300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.6643026914478E-11 |
| Normal-vs-Age(41-60Yrs) |
2.22288853990449E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.00920000001281E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.924200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.810150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.548180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.297450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.187400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.595400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.220200E-03 |
| Normal-vs-Grade 2 |
4.55249948849712E-10 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
8.744800E-01 |
| Grade 1-vs-Grade 3 |
1.763200E-01 |
| Grade 1-vs-Grade 4 |
4.65900000001795E-06 |
| Grade 2-vs-Grade 3 |
4.118200E-03 |
| Grade 2-vs-Grade 4 |
1.97619698383278E-14 |
| Grade 3-vs-Grade 4 |
9.90280002444166E-09 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.24250000000681E-05 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.63868918434673E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64057656348859E-12 |
| Normal-vs-N1 |
3.13110004590555E-09 |
| N0-vs-N1 |
5.801700E-02 |
|
|
